[Pharmacological treatment of asthma during pregnancy].

- Asthma during pregnancy is associated with an increased risk of preterm delivery, low birth weight and pre-eclampsia.- This condition may be undertreated due to insufficient knowledge and, in particular, concerns about teratogenic effects of asthma medication among treating healthcare professionals and pregnant women.- The risk of teratogenic effects of inhaled medications (ICS, SABA and LABA) is small.

Specific airway resistance is a better outcome parameter in bronchial provocation testing compared to FEV in patients with bronchial asthma.

Objectives: Asthma is a chronic inflammatory disease characterized by airway hyperresponsiveness (AHR). A bronchial provocation test (BPT) is used to test for AHR. However forced expiratory volume in one second (FEV), used as outcome parameter is effort-related, in contrast to specific airway resistance (sRaw).